Company: EDSA
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001171843-25-000866
Chunk: 108

Company: Edesa Biotech, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 2
Chunk 108
---
 (formatted in Inline XBRL and contained in Exhibit 101)

* The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of Edesa Biotech, Inc. under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

23

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Date: February 14, 2025
			EDESA BIOTECH, INC.

			/s/ Pardeep Nijhawan

			Pardeep Nijhawan, MD, Director, Chief Executive Officer and Corporate Secretary

			(Principal Executive Officer)

			Date: February 14, 2025

			/s/ Stephen Lemieux

			Stephen Lemieux, Chief Financial Officer

			(Principal Financial Officer and Duly Authorized Officer)

24